Study shows high rates of unrecognized heart valve disease in healthy seniors

FHS
June 27, 2024
7:26 am

The sheer scale of undiagnosed heart valve disease in our ageing population has been revealed for the first time, thanks to new research led by the University of East Anglia.

Opinion | When a Revolutionary Cancer Treatment Causes Cancer

Sekeres is a leukemia specialist. My patient was young, in his thirties, and had a terrible leukemia that refused to be vanquished with multiple rounds

January 28, 2024

New drug candidate found to be highly effective in treating rare sight-threatening eye infection

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly

October 27, 2023

Antengene, Hansoh partner to commercialise XPOVIO in China

XPOVIO is the world’s first approved orally available selective inhibitor of the nuclear export protein XPO1. Credit: Nemes Laszlo / Shutterstock.com. Antengene has signed a

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.